The parents of an 11-year-old female student have complained to a Colorado school district after their daughter was forced to share a bed with a biological male, transgender student.
Pfizer announced last week that it is discontinuing development of its twice-daily weight loss pill "danuglipron" after a clinical trial showed "high rates" of adverse side effects among users.
Taiwan's health ministry is urging its people who are elderly, very young, or with poor immunity to avoid traveling to China because of the uptick in respiratory illnesses in the country.
The U.S. Food and Drug Administration (FDA) is investigating the cancer treatment CAR-T after it was notified of new blood cancers among individuals who received the treatment.
